UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 821

Sortiert nach

Shaping the Nrf2-ARE-related pathways in Alzheimer's and Parkinson's diseases

Ageing research reviews, 2019-09, Vol.54, p.100942-100942, Article 100942

2019

Link zum Volltext

Verfügbarkeit prüfen

Dysfunctional synapse in Alzheimer's disease – A focus on NMDA receptors

Neuropharmacology, 2014-01, Vol.76, p.16-26

2014

Link zum Volltext

Verfügbarkeit prüfen

Mitochondrial Dysfunction in Huntington’s Disease

Polyglutamine Disorders, 2018, Vol.1049, p.59-83

2018

Link zum Volltext

Verfügbarkeit prüfen

Insulin and IGF-1 improve mitochondrial function in a PI-3K/Akt-dependent manner and reduce mitochondrial generation of reactive oxygen species in Huntington’s disease knock-in striatal cells

Free radical biology & medicine, 2014-09, Vol.74, p.129-144

2014

Link zum Volltext

Verfügbarkeit prüfen

Comparative Mitochondrial-Based Protective Effects of Resveratrol and Nicotinamide in Huntington’s Disease Models

Molecular neurobiology, 2017-09, Vol.54 (7), p.5385-5399

2017

Link zum Volltext

Verfügbarkeit prüfen

c-Src regulates Nrf2 activity through PKCδ after oxidant stimulus

Biochimica et biophysica acta. Molecular cell research, 2019-04, Vol.1866 (4), p.686-698

2019

Link zum Volltext

Verfügbarkeit prüfen

Mitochondrial Ca2+ handling in Huntington's and Alzheimer's diseases – Role of ER-mitochondria crosstalk

Biochemical and biophysical research communications, 2017-02, Vol.483 (4), p.1069-1077

2017

Link zum Volltext

Verfügbarkeit prüfen

The NAD+-dependent deacetylase SIRT2 attenuates oxidative stress and mitochondrial dysfunction and improves insulin sensitivity in hepatocytes

Human molecular genetics, 2017-11, Vol.26 (21), p.4105-4117

2017

Link zum Volltext

Verfügbarkeit prüfen

Alpha-synuclein-induced oxidative stress correlates with altered superoxide dismutase and glutathione synthesis in human neuroblastoma SH-SY5Y cells

Archives of toxicology, 2017-03, Vol.91 (3), p.1245-1259

2017

Link zum Volltext

Verfügbarkeit prüfen

Linking alpha-synuclein phosphorylation to reactive oxygen species formation and mitochondrial dysfunction in SH-SY5Y cells

Molecular and cellular neuroscience, 2014-09, Vol.62, p.51-59

2014

Link zum Volltext

Verfügbarkeit prüfen

Revisiting Mitochondrial Function and Metabolism in Pluripotent Stem Cells: Where Do We Stand in Neurological Diseases?

Molecular neurobiology, 2017-04, Vol.54 (3), p.1858-1873

2017

Link zum Volltext

Verfügbarkeit prüfen

Histone Deacetylase Inhibitors Protect Against Pyruvate Dehydrogenase Dysfunction in Huntington's Disease

The Journal of neuroscience, 2017-03, Vol.37 (10), p.2776-2794

2017

Link zum Volltext

Verfügbarkeit prüfen

The Sigma-1 Receptor Mediates Pridopidine Rescue of Mitochondrial Function in Huntington Disease Models

Neurotherapeutics, 2021-04, Vol.18 (2), p.1017-1038

2021

Link zum Volltext

Verfügbarkeit prüfen

Mechanistic perspectives on differential mitochondrial-based neuroprotective effects of several carnitine forms in Alzheimer’s disease in vitro model

Archives of toxicology, 2021-08, Vol.95 (8), p.2769-2784

2021

Link zum Volltext

Verfügbarkeit prüfen

Aβ and NMDAR activation cause mitochondrial dysfunction involving ER calcium release

Neurobiology of aging, 2015-02, Vol.36 (2), p.680-692

2015

Link zum Volltext

Verfügbarkeit prüfen

Microbial BMAA elicits mitochondrial dysfunction, innate immunity activation, and Alzheimer’s disease features in cortical neurons

Journal of neuroinflammation, 2020-11, Vol.17 (1), p.1-18, Article 332

2020

Link zum Volltext

Verfügbarkeit prüfen

Impaired transcription in Alzheimer's disease: key role in mitochondrial dysfunction and oxidative stress

Journal of Alzheimer's disease, 2013-01, Vol.34 (1), p.115

2013

Link zum Volltext

Verfügbarkeit prüfen

IGF-1 Intranasal Administration Rescues Huntington's Disease Phenotypes in YAC128 Mice

Molecular neurobiology, 2014-06, Vol.49 (3), p.1126-1142

2014

Link zum Volltext

Verfügbarkeit prüfen

Mitochondrial dysfunction and reactive oxygen species in excitotoxicity and apoptosis: Implications for the pathogenesis of neurodegenerative diseases

Neurochemical research, 2003-10, Vol.28 (10), p.1563-1574

2003

Link zum Volltext

Verfügbarkeit prüfen

Glutathione redox cycle dysregulation in Huntington’s disease knock-in striatal cells

Free radical biology & medicine, 2012-11, Vol.53 (10), p.1857-1867

2012

Link zum Volltext

Verfügbarkeit prüfen

Activation of IGF-1 and Insulin Signaling Pathways Ameliorate Mitochondrial Function and Energy Metabolism in Huntington’s Disease Human Lymphoblasts

Molecular neurobiology, 2015-02, Vol.51 (1), p.331-348

2015

Link zum Volltext

Verfügbarkeit prüfen

Assessing Mitochondrial Function in In Vitro and Ex Vivo Models of Huntington's Disease

Methods in molecular biology (Clifton, N.J.), 2018-01, Vol.1780, p.415

2018

Link zum Volltext

Verfügbarkeit prüfen

Mitochondrial and redox modifications in early stages of Huntington's disease

Redox biology, 2022-10, Vol.56, p.102424-102424, Article 102424

2022

Link zum Volltext

Verfügbarkeit prüfen

An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer's disease

Journal of Alzheimer's disease, 2009-01, Vol.16 (4), p.741

2009

Link zum Volltext

Verfügbarkeit prüfen

Expanded and Wild-type Ataxin-3 Modify the Redox Status of SH-SY5Y Cells Overexpressing α-Synuclein

Neurochemical research, 2017-05, Vol.42 (5), p.1430-1437

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 821

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(694)
Mit Volltextzugriff
(754)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(16)
... seit 30 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Shaping the Nrf2-ARE-related pathways in Alzheimer's and Parkinson's diseases

Dysfunctional synapse in Alzheimer's disease – A focus on NMDA receptors

Mitochondrial Dysfunction in Huntington’s Disease

Insulin and IGF-1 improve mitochondrial function in a PI-3K/Akt-dependent manner and reduce mitochondrial generation of reactive oxygen species in Huntington’s disease knock-in striatal cells

Comparative Mitochondrial-Based Protective Effects of Resveratrol and Nicotinamide in Huntington’s Disease Models

c-Src regulates Nrf2 activity through PKCδ after oxidant stimulus

Mitochondrial Ca2+ handling in Huntington's and Alzheimer's diseases – Role of ER-mitochondria crosstalk

The NAD+-dependent deacetylase SIRT2 attenuates oxidative stress and mitochondrial dysfunction and improves insulin sensitivity in hepatocytes

Alpha-synuclein-induced oxidative stress correlates with altered superoxide dismutase and glutathione synthesis in human neuroblastoma SH-SY5Y cells

Linking alpha-synuclein phosphorylation to reactive oxygen species formation and mitochondrial dysfunction in SH-SY5Y cells

Revisiting Mitochondrial Function and Metabolism in Pluripotent Stem Cells: Where Do We Stand in Neurological Diseases?

Histone Deacetylase Inhibitors Protect Against Pyruvate Dehydrogenase Dysfunction in Huntington's Disease

The Sigma-1 Receptor Mediates Pridopidine Rescue of Mitochondrial Function in Huntington Disease Models

Mechanistic perspectives on differential mitochondrial-based neuroprotective effects of several carnitine forms in Alzheimer’s disease in vitro model

Aβ and NMDAR activation cause mitochondrial dysfunction involving ER calcium release

Microbial BMAA elicits mitochondrial dysfunction, innate immunity activation, and Alzheimer’s disease features in cortical neurons

Impaired transcription in Alzheimer's disease: key role in mitochondrial dysfunction and oxidative stress

IGF-1 Intranasal Administration Rescues Huntington's Disease Phenotypes in YAC128 Mice

Mitochondrial dysfunction and reactive oxygen species in excitotoxicity and apoptosis: Implications for the pathogenesis of neurodegenerative diseases

Glutathione redox cycle dysregulation in Huntington’s disease knock-in striatal cells

Activation of IGF-1 and Insulin Signaling Pathways Ameliorate Mitochondrial Function and Energy Metabolism in Huntington’s Disease Human Lymphoblasts

Assessing Mitochondrial Function in In Vitro and Ex Vivo Models of Huntington's Disease

Mitochondrial and redox modifications in early stages of Huntington's disease

An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer's disease

Expanded and Wild-type Ataxin-3 Modify the Redox Status of SH-SY5Y Cells Overexpressing α-Synuclein

Suchergebnisse filtern